Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Jeanne Shaheen

Lawmakers eye lame duck for unfinished business on insulin - Roll Call

A bipartisan insulin affordability measure faces myriad obstacles, but a Senate duo hope the lame duck offers promise for passage.

Roll Call

Afghan visa program falls short of promises, senator’s review finds

SIV program “has not lived up to the promise we made to participants” and requires policy changes to meet its full potential, a review found.

Roll Call

States make pitches to vote 1st in 2024 Democratic primaries

Sixteen states and Puerto Rico are jockeying for early slots on a new Democratic presidential primary calendar, offering presentations for party bosses on why they deserve to go first — or at least close to it

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Proposed insulin price cap poses test for Dems

A Senate deal to cap the cost of insulin at $35 a month for individuals with private insurance and Medicare poses a new test of whether Democrats can make good on campaign pledges to rein in drug costs, Axios' Adriel Bettelheim writes.

Axios

Senators release bill targeting insulin prices

WASHINGTON — Two key senators on Wednesday released a widely anticipated bill aimed at lowering insulin prices and capping monthly copays under commercial and Medicare insurance plans.

Tribune News Service

Senators release bill targeting insulin prices - Roll Call

The bill would cap insulin copays at the lesser of $35 or 25 percent of the list price per month in commercial and Medicare Part D plans.

Roll Call

Capitol Lens | Moose on the loose - Roll Call

Today’s Capitol Lens sees staffers from New Hampshire Sen. Jeanne Shaheen’s office unloading “Marty the Moose” from a Hart Senate Building freight elevator.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

Biden’s plea for gun control draws fire and praise from the usual quarters

The reactions followed familiar party lines: Democrats agree it’s time to act, Republicans call the speech ‘divisive’

The Guardian - US

Kyiv's envoy backs using frozen Russian state assets to rebuild Ukraine - Roll Call

The government of Ukraine backs the United States seizing frozen Russian government assets and using them to rebuild the country.

Roll Call

Senators say Pentagon must do more to help Ukraine defeat Russia - Roll Call

Senators pressed Defense Department leaders to send more weapons to Ukraine more quickly, with the goal of defeating Russia.

Roll Call

With Senate readying vote on insulin bill, advocates seek changes

WASHINGTON — Advocates and some lawmakers are hoping to add provisions for the uninsured to a Senate bill that would cap insulin copays for some insured patients — and to do so before the chamber votes on the measure, possibly this month.

Tribune News Service

With Senate readying vote on insulin bill, advocates seek changes - Roll Call

As the Senate prepares to vote on an insulin pricing bill as early as this month, advocates and some lawmakers try to expand its reach.

Roll Call

House passes bill to lower insulin costs, but prospects unclear in Senate

WASHINGTON — The House moved Thursday to revive one of the more popular provisions of last year’s failed social safety net package, passing a narrow healthcare bill that would dramatically lower out-of-pocket costs for insulin users.

Los Angeles Times

Congress should pass defense budget to deter Putin, senators say - Roll Call

A bipartisan group of senators pressed to pass a defense funding bill and said it would help deter Russian aggression.

Roll Call

Get all your
news in one place.

100's of premium titles.
One news app.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Kaiser Family Foundation

32 stories

Senate Foreign Relations

11 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.